Beck Bode LLC’s GSK GSK Stock Holding History

Beck Bode LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,666	Closed	-$961K	–	219
2022 Q3	$961K	Buy	+32,666	New	+$1.24M	0.21%	99
2020 Q4	–	Sell	-443	Closed	-$21K	–	126
2020 Q3	$21K	Buy	+443	New	+$22.2K	0.01%	164

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Beck Bode LLC's GSK Position: Q4 2022 in Review

Beck Bode LLC sold out of GSK (GSK) in Q4 2022, closing a stake of 32,666 shares — an estimated $961K sold.

Beck Bode LLC first reported a position in GSK in Q3 2020 and held it in 2 quarters. The position peaked at $961K in Q3 2022. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Beck Bode LLC reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
Beck Bode LLC sold 32,666 GSK shares in Q4 2022, an estimated $961K.
Beck Bode LLC first reported a position in GSK in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's GSK position peaked at $961K in Q3 2022.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Beck Bode LLC's 13F filing for Q4 2022, filed 8 Feb 2023.